12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Harbour Antibodies, Shang Pharma deal

ShangPharma will use Harbour's human immunoglobulin-gene transgenic mice for human antibody development services....

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >